Table 1.
S.N. | Study model | Treatment | Mode of inhibition | Observations | References |
---|---|---|---|---|---|
1 | MPTP-induced PD mouse model | Anti-HMGB1 mAb | Neutralization | Inhibits dopaminergic cell death and reduces RAGE and TNF-α levels | (20) |
2 | 6-OHDA-induced PD mouse model | Anti-HMGB1 mAb | Neutralization | inhibits the activation of microglia, the destruction of the BBB and the expression of IL-1β and IL-6 Reduced PD behavioral symptoms |
(28) |
3 | MPTP-induced PD mouse model | EP | Release inhibition | Restoration of dopaminergic neuron numbers in substantia nigra and striatum | (29) |
4 | MPTP-induced PD zebrafish larvae model | GL | Release inhibition | Increases the length of DA neurons in the zebrafish brain and reduces the number of apoptotic cells in the zebrafish brain | (30) |